2024-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 69 <0.0001% | $430.93 | $29,734 | +7.49% | |
2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 5,034 0.0019% | $425.70 | $2.14M | -3.7% | |
2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 3,603 0.0014% | $421.77 | $1.52M | -0.31% | |
2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 4,804 0.0019% | $420.79 | $2.02M | -0.48% | |
2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 4,295 0.0017% | $420.24 | $1.8M | +0.03% | |
2023-12-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 8,603 0.0033% | $399.00 | $3.43M | +3.7% | |
2023-06-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 8,603 0.0033% | $349.00 | $3M | +12.66% | |
2023-05-30 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 82 <0.0001% | $329.82 | $27,045 | +14.05% | |
2023-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 5,034 0.002% | $287.47 | $1.45M | +21.88% | |
2023-02-22 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 2,401 0.0009% | $294.33 | $706,679 | +18.89% | |
2023-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 2,402 0.0009% | $293.75 | $705,596 | +19.61% | |
2023-02-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 6,398 0.0025% | $298.68 | $1.91M | +16.39% | |
2023-02-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 4,887 0.0019% | $298.92 | $1.46M | +16.78% | |
2022-08-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 6,948 0.0027% | $305.38 | $2.12M | +2.06% | |
2022-08-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 9 <0.0001% | $302.01 | $2,718 | +5.18% | |
2022-08-09 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 900 0.0004% | $301.42 | $271,278 | +3.99% | |
2022-05-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 20 <0.0001% | $249.35 | $4,987 | +15.78% | |
2022-05-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 306 0.0001% | $263.98 | $80,778 | +11.94% | |
2021-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, COO | 3 <0.0001% | $187.26 | $562 | +44.25% | |
2021-05-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Comm & Ops Officer | 109 <0.0001% | $216.41 | $23,589 | -4.41% |